Abstract:Background Growing evidence suggests that cancer stem cells (CSCs) are responsible for cancer initiation in tumors. Bach1 has been identified to contribute to several tumor progression, including lung cancer. The role of Bach1 in CSCs remains poorly known. Therefore, the function of Bach1 on lung CSCs was focused currently. Methods The expression of Bach1, CD133, CD44, Sox2, Nanog and Oct4 mRNA was assessed using Real-Time Quantitative Reverse Transcription PCR (RT-qPCR). Protein expression of Bach1, CD133, CD44, Sox2, Nanog, Oct4, p53, BCL2, BAX, p-p38, p-AKT1, c-Fos and c-Jun protein was analyzed by western blotting. 5-ethynyl-29-deoxyuridine (EdU), colony formation, Flow cytometry analysis and transwell invasion assay were carried out to analyze lung cancer cell proliferation, apoptosis and invasion respectively. Tumor sphere formation assay was utilized to evaluate spheroid capacity. Flow cytometry analysis was carried out to isolate CD133 or CD44 positive lung cancer cells. The relationship between Bach1 and CD44 was verified using ChIP-qPCR and dual-luciferase reporter assay. Xenograft tumor tissues were collected for hematoxylin and eosin (HE) staining and IHC analysis to evaluate histology and Ki-67. Results The ratio of CD44 + CSCs from A549 and SPC-A1 cells were significantly enriched. Tumor growth of CD44 + CSCs was obviously suppressed in vivo compared to CD44− CSCs. Bach1 expression was obviously increased in CD44 + CSCs. Then, via using the in vitro experiment, it was observed that CSCs proliferation and invasion were greatly reduced by the down-regulation of Bach1 while cell apoptosis was triggered by knockdown of Bach1. Loss of Bach1 was able to repress tumor-sphere formation and tumor-initiating CSC markers. A repression of CSCs growth and metastasis of shRNA-Bach1 was confirmed using xenograft models and caudal vein injection. The direct interaction between Bach1 and CD44 was confirmed by ChIP-qPCR and dual-luciferase reporter assay. Furthermore, mitogen-activated protein kinases (MAPK) signaling pathway was selected and we proved the effects of Bach1 on lung CSCs were associated with the activation of the MAPK pathway. As manifested, loss of Bach1 was able to repress p-p38, p-AKT1, c-Fos, c-Jun protein levels in lung CSCs. Inhibition of MAPK signaling remarkably restrained lung CSCs growth and CSCs properties induced by Bach1 overexpression. Conclusion In summary, we imply that Bach1 demonstrates great potential for the treatment of lung cancer metastasis and recurrence via activating CD44 and MPAK signaling.

Overexpression of BACH1 mediated by IGF2 facilitates hepatocellular carcinoma growth and metastasis via IGF1R and PTK2

CHI3L1 Promotes Tumor Progression by Activating TGF-β Signaling Pathway in Hepatocellular Carcinoma.

Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy

Uncovering BTB and CNC Homology1 (BACH1) as a Novel Cancer Therapeutic Target

BACH1 is Transcriptionally Inhibited by TET1 in Hepatocellular Carcinoma in a Microrna-34A-dependent Manner to Regulate Autophagy and Inflammation

BTB and CNC Homology 1 (bach1) Promotes Human Ovarian Cancer Cell Metastasis by HMGA2-mediated Epithelial-Mesenchymal Transition

BTB and CNC Homology 1 (bach1) Induces Lung Cancer Stem Cell Phenotypes by Stimulating CD44 Expression.

Transcriptional network analysis identifies BACH1 as a master regulator of breast cancer bone metastasis.

LncRNA TRG-AS1 Stimulates Hepatocellular Carcinoma Progression by Sponging Mir-4500 to Modulate BACH1

BACH1: A Potential Predictor of Survival in Early-Stage Lung Adenocarcinoma

LINC01419-mediated epigenetic silencing of ZIC1 promotes metastasis in hepatocellular carcinoma through the PI3K/Akt signaling pathway

Overexpression of Bmi-1 Contributes to the Invasion and Metastasis of Hepatocellular Carcinoma by Increasing the Expression of Matrix Metalloproteinase (MMP)-2, MMP-9 and Vascular Endothelial Growth Factor Via the PTEN/PI3K/Akt Pathway

Abstract 386: BACH1 is a key regulator of the tumor hypoxia response

CircBACH1 (hsa_circ_0061395) Promotes Hepatocellular Carcinoma Growth by Regulating P27 Repression Via HuR.

Protein Tyrosine Phosphatase PTP4A1 Promotes Proliferation and Epithelial-Mesenchymal Transition in Intrahepatic Cholangiocarcinoma Via the PI3K/AKT Pathway

Functional role of BTB and CNC Homology 1 gene in pancreatic cancer and its association with survival in patients treated with gemcitabine.

Long Noncoding RNA 91H Overexpression Contributes to the Growth and Metastasis of HCC by Epigenetically Positively Regulating IGF2 Expression.

Thioredoxin facilitates hepatocellular carcinoma stemness and metastasis by increasing BACH1 stability to activate the AKT/mTOR pathway

LAPTM4B Facilitates Tumor Growth and Induces Autophagy in Hepatocellular Carcinoma

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway

MYBBP1A‑mediated IGFBP4 Promoter Methylation Promotes Epithelial‑mesenchymal Transition and Metastasis Through Activation of NOTCH Pathway in Liver Cancer